Skip to main content

Lluis Armadans Gil

Institutions of which they are part

Senior researcher
Epidemiology and Public Health
Vall Hebron Institut de Recerca

Lluis Armadans Gil

Institutions of which they are part

Senior researcher
Epidemiology and Public Health
Vall Hebron Institut de Recerca

Projects

Ensayo clínico para comparar la inmunogenicidad de una vacuna anti-hepatitis B adyuvada con la de carga antigénica aunmentada en pacientres inmunodeprimidos.

IP: -
Collaborators: Manuel Hernández González, Rosa Lopez Martinez , Lluis Armadans Gil, Alexandre Martínez Marti, Laia Pinos Tella, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Blanca Borras Bermejo, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil
Funding agency: Instituto de Salud Carlos III
Funding: 73205
Reference: PI18/01887
Duration: 01/01/2019 - 30/06/2023

Factores virológicos y del huésped asociados a una mayor gravedad de la infección por el virus respiratorio sincitial (VRS)

IP: Tomàs Pumarola Suñé
Collaborators: Jose Angel Rodrigo Pendás, Andres Antón Pagarolas, Lluis Armadans Gil, Juliana Esperalba Esquerra
Funding agency: Instituto de Salud Carlos III
Funding: 116765
Reference: PI14/01838
Duration: 01/01/2015 - 30/06/2019

Establecimiento de un modelo para mejorar la comparabilidad de los resultados del Estudiio de Prevalencia de las Infecciones Nosocomiales en España (EPINE)

IP: -
Collaborators: Lluis Armadans Gil
Funding agency: Instituto de Salud Carlos III
Funding: 45375
Reference: PI07/90255
Duration: 01/01/2008 - 31/12/2009

Análisis de la evolución de la prevalencia de las infecciones nosocomiales en España.

IP: -
Collaborators: Lluis Armadans Gil
Funding agency: Instituto de Salud Carlos III
Funding: 7590
Reference: PI020765
Duration: 06/11/2002 - 06/11/2004

Related news

The Lancet Neurology publishes the new criteria, the result of a global expert consensus led by Dr Xavier Montalban.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

This strategy protects almost two thirds of patients. It also reduces the waiting time between vaccination and initiation of immune suppressive treatment.

Related professionals

Marc Simo Perdigo

Marc Simo Perdigo

Molecular Imaging and Therapy
Read more
Richard Miguel Lomas Albuja

Richard Miguel Lomas Albuja

Ethics Committees Support Unit (USCE)
External Strategy Directorate
Read more
Joaquim Sola  Santesmases

Joaquim Sola Santesmases

General Services and Infrastructures Unit
Infrastructure Coordination
Manager
Read more
Katerina Papadakis

Katerina Papadakis

Internal Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.